Regeneron Pharmaceuticals, Inc. (REGN)
729.55
-3.49
(-0.48%)
USD |
NASDAQ |
Jan 20, 10:40
Regeneron Pharmaceuticals Research and Development Expense (Quarterly): 1.338B for Sept. 30, 2025
Research and Development Expense (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Data
R&D Expense Definition
R&D expense is a line item from many companies' income statements.
Research and Development Expense (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Research and Development Expense (Quarterly) Benchmarks
| Amgen, Inc. | 1.90B |
| Gilead Sciences, Inc. | 1.334B |
| Johnson & Johnson | 3.693B |
| Eli Lilly & Co. | 3.466B |
| Merck & Co., Inc. | 3.552B |